Title of article :
Evaluation of Rubella IgG Antibodies Among Women at Marriage in Kermanshah City, Before and After Mass Vaccination
Author/Authors :
Hatami، Hossein نويسنده , , Mansouri، Feizollah نويسنده Department of Infectious Diseases, Imam Reza Hospital, Kermanshah University of Medical Sciences , , Mehrabi، Yadollah نويسنده , , Namdari، Hengameh نويسنده Epidemiology Executive of Center for Diseases Management, Tehran , , Hatami، Maryam نويسنده ,
Issue Information :
ماهنامه با شماره پیاپی 0 سال 2013
Abstract :
Background: Rubella is a mild viral infectious disease, usually
occurs subclinically without a serious complication. But if occurs
during pregnancy, specially the first trimester, it can transmit and
invade to fetus causing congenital rubella syndrome or fetal death.
In 2003, nearly all Iranians at the age of 5 to 25 years old were
vaccinated against rubella and the vaccine was included in the
compulsory immunization, MMR afterwards.
Methods: This study was carried out on girls attended at a marriage
consultancy center in Kermanshah city (West of Iran) in 2006.
Considering 95% of confidence, the sample size was estimated at
140. All samples were tested using ELISA serologic method and
compared with similar study conducted on 240 unvaccinated girls
at the same place in 1999.
Results: Antibody positivity was observed in 99.3%, compared
to 79.58% of the previous study. A rise of 19.72% (95% CI
12.7%-26.7%) of seropositivity was observed in vaccinated girls
versus unvaccinated ones (P < 0.001).
Conclusion: In our previous study, we had recommended to screen
for susceptibility to rubella before marriage, which is no longer
required since more than 99% of vaccinated girls showed immunity
at the time of marriage. However, as sustainability of immunity after
rubella vaccination is usually less than immunity due to illness, we
recommend screening for rubella protective antibody every few years.
Journal title :
International Journal of Preventive Medicine (IJPM)
Journal title :
International Journal of Preventive Medicine (IJPM)